Hongwu Chen:Research

Hongwu Chen Laboratory

Cancer Therapeutics Development Lab

Department of Biochemisrty & Molecular Medicine, University of California, Davis

Home       Research       Publications       Lab Members    
Contact       Gallery       Collaborators    Protocols&Lab Resources

Our current research focuses are the followings: Exploring nuclear receptor (NR) sub-family members, such as the retinoid receptor-related receptors (RORs)/NR1Fs, as novel therapeutic targets for advanced cancers (e.g. mCRPC); Exploring key epigenetic regulators including the histone demethylases (e.g. KDM4s) and bromodomain proteins (e.g. ANCCA/ATAD2) as novel therapeutic targets for cancer; Elucidating the functional mechanisms of key epigenetic regulators and nuclear receptors in tumorigenesis and therapeutic resistance; Developing biomarkers for guiding effective targeted therapies.